Last 37 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | 18.38 | — | 1032.64 | — | 4.95 | 54.56 | — | 403.44 | 40.30 | 87.94 | 104.55 | — | 103.79 | — | — | — | 629.70 | — | — | — | — |
| — | — | — | — | -87.7% | -38.0% | — | — | -61.2% | — | — | — | -83.5% | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.09 | 2.43 | 1.61 | 1.81 | 2.50 | 2.45 | 4.41 | 6.00 | 5.95 | 7.95 | 5.19 | 9.70 | 7.99 | 9.50 | 15.70 | 13.31 | 13.79 | 11.46 | 13.79 | 25.45 | 20.08 |
| — | -0.8% | -63.5% | -69.8% | -57.9% | -69.3% | -15.1% | -38.2% | -25.6% | -16.3% | -66.9% | -27.2% | -42.1% | -17.1% | +13.9% | -47.7% | -31.3% | -55.5% | -44.5% | -26.9% | -27.2% | |
| P/B Ratio | 2.44 | 2.43 | 1.56 | 1.87 | 3.45 | 3.30 | 5.65 | 7.59 | 8.27 | 9.28 | 6.38 | 10.80 | 10.74 | 10.71 | 17.93 | 13.49 | 15.34 | 10.65 | 22.21 | 31.39 | 27.50 |
| — | -26.4% | -72.3% | -75.4% | -58.3% | -64.5% | -11.4% | -29.7% | -23.1% | -13.3% | -64.4% | -20.0% | -30.0% | +0.6% | -19.3% | -57.0% | -44.2% | -63.1% | -7.2% | +24.6% | +24.5% | |
| P/FCF | 18.83 | 12.90 | 22.94 | 118.51 | 16.11 | 9.45 | — | — | 22.93 | 36.51 | — | — | 166.53 | — | 10009.71 | — | 116.57 | 167.11 | — | — | 7832.97 |
| — | +36.5% | — | — | -29.7% | -74.1% | — | — | -86.2% | — | — | — | +42.9% | — | — | — | -98.5% | — | — | — | — | |
| EV / EBITDA | 51.43 | — | 73.01 | 88.36 | 13.28 | 39.71 | 9579.73 | 770.95 | 40.61 | 98.08 | 150.65 | — | 148.07 | — | — | — | 7667.15 | — | — | — | — |
| — | — | -99.2% | -88.5% | -67.3% | -59.5% | +6259.0% | — | -72.6% | — | — | — | -98.1% | — | — | — | — | — | — | — | — | |
| EV / EBIT | 34.75 | — | — | 147.16 | 13.14 | 39.01 | — | 288.99 | 25.71 | 78.02 | 90.03 | — | 98.27 | — | — | — | 547.82 | — | — | — | — |
| — | — | — | -49.1% | -48.9% | -50.0% | — | — | -73.8% | — | — | — | -82.1% | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 85.4% | 86.0% | 85.5% | 86.5% | 86.6% | 85.8% | 84.0% | 84.7% | 85.0% | 84.1% | 84.8% | 84.9% | 85.4% | 84.1% | 83.9% | 84.5% | 83.9% | 81.9% | 84.5% | 85.6% | 85.8% |
| — | +0.2% | +1.7% | +2.0% | +1.9% | +2.1% | -0.9% | -0.2% | -0.5% | -0.0% | +1.0% | +0.5% | +1.8% | +2.7% | -0.6% | -1.3% | -2.1% | -4.8% | -1.5% | +0.5% | +1.6% | |
| Operating Margin | 5.6% | -13.9% | -0.3% | -0.5% | 17.1% | 4.3% | -1.5% | -0.7% | 13.3% | 7.0% | 2.6% | -9.3% | 4.8% | -8.8% | -11.0% | -15.2% | -0.2% | -15.7% | -15.3% | -23.1% | -2.3% |
| — | -423.4% | +83.2% | +25.9% | +28.8% | -39.0% | -158.7% | +92.1% | +175.4% | +180.2% | +123.7% | +39.1% | +2088.2% | +44.2% | +28.3% | +34.1% | +89.5% | +0.8% | +35.3% | +40.5% | +84.9% | |
| Net Margin | 15.9% | -11.8% | 0.2% | -5.5% | 50.6% | 4.4% | -1.7% | 1.5% | 14.7% | 9.1% | 5.0% | -6.1% | 7.7% | -5.6% | -7.9% | -12.1% | 2.3% | -15.4% | -15.9% | -24.1% | -3.0% |
| — | -366.8% | +109.5% | -471.5% | +244.2% | -51.4% | -133.1% | +124.4% | +91.6% | +263.4% | +163.2% | +49.4% | +235.7% | +63.9% | +50.1% | +49.9% | +174.9% | +8.0% | +35.8% | +40.1% | +81.3% |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 19.8% | -3.0% | 0.0% | -1.4% | 18.8% | 1.5% | -0.5% | 0.5% | 5.1% | 2.8% | 1.6% | -1.7% | 2.6% | -1.6% | -2.3% | -3.1% | 0.7% | -4.8% | -6.4% | -7.4% | -1.1% |
| — | -299.8% | +107.1% | -417.9% | +270.0% | -46.7% | -134.3% | +126.2% | +92.2% | +274.2% | +169.0% | +44.1% | +305.5% | +67.1% | +63.9% | +58.1% | +161.3% | -2.8% | -8.5% | -2.7% | +67.4% | |
| ROA | 17.0% | -2.6% | 0.0% | -1.2% | 15.8% | 1.2% | -0.5% | 0.4% | 4.4% | 2.4% | 1.4% | -1.5% | 2.2% | -1.4% | -2.0% | -2.7% | 0.6% | -4.1% | -5.0% | -5.7% | -0.8% |
| — | -310.4% | +107.3% | -417.5% | +259.1% | -49.1% | -133.8% | +126.5% | +95.7% | +278.7% | +168.9% | +45.9% | +289.0% | +67.0% | +59.7% | +52.5% | +169.2% | -9.5% | -3.8% | +2.4% | +69.2% | |
| ROIC | 6.0% | -3.1% | -0.1% | -0.1% | 5.2% | 1.2% | -0.4% | -0.2% | 4.2% | 2.0% | 0.8% | -2.7% | 2.1% | -6.2% | -15.9% | -21.8% | -0.4% | -19.4% | -16.4% | -23.0% | -3.0% |
| — | -354.6% | +87.0% | +38.9% | +25.1% | -40.6% | -148.7% | +93.0% | +95.0% | +132.9% | +105.3% | +87.7% | +631.8% | +67.9% | +3.4% | +5.4% | +86.8% | -52.0% | -27.4% | -38.2% | +58.4% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.03 | 0.04 | 0.04 | 0.08 | 0.05 | 0.05 | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | 0.04 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.14 | 0.15 | 0.15 |
| — | -29.2% | -27.7% | -29.3% | +72.6% | +34.4% | +27.0% | +26.8% | +6.2% | -21.4% | -13.0% | +145.5% | +142.6% | +138.2% | -68.0% | -88.9% | -88.0% | -86.2% | -1.7% | +10.5% | +11.6% | |
| Debt / EBITDA | 0.50 | — | 7.13 | 7.40 | 1.24 | 2.45 | 337.34 | 21.50 | 0.93 | 1.57 | 3.78 | — | 2.46 | — | — | — | 37.91 | — | — | — | — |
| — | — | -97.9% | -65.6% | +34.5% | +56.1% | +8820.6% | — | -62.3% | — | — | — | -93.5% | — | — | — | — | — | — | — | — | |
| Current Ratio | 6.08 | 6.45 | 8.55 | 6.34 | 6.08 | 5.29 | 6.14 | 9.01 | 7.13 | 7.84 | 9.25 | 7.93 | 7.60 | 8.14 | 8.40 | 8.91 | 8.66 | 10.05 | 5.62 | 6.08 | 6.50 |
| — | +21.9% | +39.3% | -29.6% | -14.8% | -32.5% | -33.6% | +13.6% | -6.2% | -3.6% | +10.1% | -11.0% | -12.2% | -19.1% | +49.5% | +46.6% | +33.3% | +32.2% | -45.2% | -54.7% | -50.1% | |
| Quick Ratio | 4.56 | 4.61 | 6.16 | 4.48 | 4.56 | 4.01 | 4.84 | 7.44 | 6.22 | 6.94 | 8.35 | 7.25 | 7.17 | 7.76 | 8.09 | 8.65 | 8.47 | 9.75 | 5.15 | 5.57 | 6.08 |
| — | +14.9% | +27.3% | -39.8% | -26.7% | -42.2% | -42.1% | +2.6% | -13.2% | -10.7% | +3.2% | -16.2% | -15.4% | -20.3% | +57.0% | +55.4% | +39.2% | +36.5% | -46.9% | -56.7% | -51.8% | |
| Interest Coverage | 480.54 | — | — | — | 413.45 | 1232.91 | -582.00 | — | 2467.09 | — | — | — | — | — | — | — | — | -24.31 | -28.04 | -30.49 | -3.41 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 37 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying INSP stock.
Inspire Medical Systems, Inc.'s current P/E is 18.4x. The average P/E over the last 2 quarters is 518.8x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Inspire Medical Systems, Inc.'s current operating margin is 5.6%. Margins have been compressing over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking Inspire Medical Systems, Inc.'s business trajectory between earnings reports.